发明名称 Recombinant human interferon-like proteins and method of treatment using them
摘要 This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology is described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human inteferon like alpha 2b(HuIFN-α2b). The invention encompasses a polynucleotide encoding the protein and recombinant vectors and host cells comprising the polynucleotide. Preferably the polynucleotide is selected from the group of polynucleotides each having a sequence at least 93% identical to SEQ ID: No. 1 and the protein is selected from the group of proteins each having an amino acid sequence at least 85% identical to SEQ ID No: 2. The proteins and compositions comprising the proteins can be used for treatment of conditions responsive to interferon therapy, such as viral diseases and cancer.
申请公布号 US9234022(B2) 申请公布日期 2016.01.12
申请号 US201313841679 申请日期 2013.03.15
申请人 Novagen Holding Corporation 发明人 Wang Haitao;Mao Chunsheng;Li Jizhi;Wang Ling;Du Yong;Liu Longbin;Xu Jing;Zhang Rui
分类号 A61K38/21;C07K14/00;C08H1/02;C07K14/56;C07K14/555;C12P21/04;C07H21/04;A61K38/00 主分类号 A61K38/21
代理机构 Seed IP Law Group PLLC 代理人 Seed IP Law Group PLLC
主权项 1. A non-naturally occurring protein exhibiting human interferon-like biological activities, wherein said protein is selected from the group consisting of proteins each comprising an amino acid sequence at least 89% identical to SEQ ID No: 2.
地址 George Town KY
您可能感兴趣的专利